Product image of Meforal (Metformin Hydrochloride) supplied by GNH India

Meforal

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Meforal (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Meforal, is a biguanide presented as an oral tablet for oral use. It is employed to improve blood glucose control in adults with type 2 diabetes mellitus.

GNH India supplies Meforal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured batches that meet EU regulatory standards and providing reliable logistics for global distribution. The company follows stringent quality control and provides regulatory documentation to support import and clinical use.

Manufacturer / TM Owner

Laboratori Guidotti S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Meforal (metformin hydrochloride) is an oral antidiabetic agent indicated for conditions involving abnormal glucose metabolism.
  • Type 2 diabetes mellitus: reduces fasting and post‑prandial blood glucose levels, improving overall glycemic control and reducing long‑term complications.
  • Impaired glucose tolerance (prediabetes): enhances insulin sensitivity and lowers hepatic glucose output, helping to delay or prevent progression to type 2 diabetes in at‑risk individuals.

How It Works

  • Metformin hydrochloride primarily inhibits mitochondrial respiratory‑chain complex I, decreasing hepatic gluconeogenesis. It also activates AMP‑activated protein kinase (AMPK), which enhances insulin‑mediated peripheral glucose uptake in muscle and adipose tissue and reduces intestinal glucose absorption. These combined actions lower circulating glucose without directly stimulating insulin secretion.

Side Effects

Metformin is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects

  • Gastrointestinal upset: nausea, abdominal discomfort, or diarrhea.
  • Metallic taste in the mouth.
  • Loss of appetite.
  • Mild headache.

Serious or Rare Side Effects

  • Lactic acidosis: a rare but potentially fatal accumulation of lactate.
  • Vitamin B12 deficiency: may develop with long‑term therapy.
  • Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Hepatic dysfunction or unexplained hypoglycemia when combined with other glucose‑lowering agents.

Precautions & Warnings

Precautions

  • Renal function: assess creatinine clearance before initiating therapy and monitor periodically.
  • Hepatic function: avoid use in patients with significant liver disease.
  • Cardiovascular status: use cautiously in patients with congestive heart failure.
  • Alcohol consumption: limit intake to reduce risk of lactic acidosis.
  • Pregnancy and lactation: safety not established; evaluate risk‑benefit with a healthcare professional.
  • Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

Avoid Interactions

Interactions

Major Interactions (Avoid)

  • Iodinated contrast agents: may cause acute renal failure; discontinue metformin before and after imaging.
  • Cimetidine: can increase metformin plasma concentrations, raising lactic acidosis risk.
  • Excessive alcohol: enhances risk of lactic acidosis.
  • Renal‑toxic drugs (e.g., aminoglycosides, NSAIDs): may impair metformin clearance.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask symptoms of hypoglycemia.
  • Thiazide diuretics: can increase blood glucose, requiring dose adjustment.
  • Corticosteroids: may reduce metformin efficacy.
  • ACE inhibitors: monitor renal function and electrolytes during combined therapy.

Frequently Asked Questions

Meforal contains metformin hydrochloride and is prescribed to lower elevated blood glucose levels in adults with type 2 diabetes mellitus. By improving insulin sensitivity and reducing hepatic glucose output, it helps achieve target glycemic control and reduces the risk of diabetes‑related complications.

Metformin hydrochloride inhibits mitochondrial complex I, which suppresses hepatic gluconeogenesis. It also activates AMP‑activated protein kinase, enhancing peripheral glucose uptake and decreasing intestinal glucose absorption. These mechanisms lower circulating glucose without stimulating insulin secretion.

The appropriate dose of Meforal is individualized by the prescribing healthcare professional. Dosage decisions consider factors such as the patient’s renal function, age, baseline glycemic control, concomitant medications, and overall treatment goals.

The safety of metformin hydrochloride in pregnancy and lactation has not been definitively established. Clinicians weigh potential benefits against possible risks, and the decision to use Meforal during pregnancy or while breastfeeding should be made in consultation with a qualified healthcare provider.

To request Meforal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Meforal belongs to the biguanide class, which differs from sulfonylureas, DPP‑4 inhibitors, or SGLT2 inhibitors. Unlike insulin‑secretagogues, metformin does not cause hypoglycemia when used alone and offers benefits such as weight neutrality and cardiovascular risk reduction, making it a first‑line option for many patients.

Meforal tablets should be stored at ambient temperature, below 25 °C, in their original packaging. Protect them from moisture, heat and direct sunlight. Keep the product out of reach of children and do not use after the expiry date.

Meforal is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water. The exact dosing schedule and timing are determined by the prescribing clinician.

The most serious adverse events linked to metformin include lactic acidosis, which is rare but life‑threatening, and vitamin B12 deficiency that can develop with long‑term use. Patients should be monitored for unexplained fatigue, muscle pain, or neuropathic symptoms, and periodic B12 testing may be advised.

Meforal is contraindicated in individuals with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, significant hepatic disease, or a history of lactic acidosis. It should also be avoided in patients with known hypersensitivity to metformin or other biguanides.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT